https://www.selleckchem.com/pr....oducts/ro5126766-ch5
[This corrects the article DOI 10.1080/2162402X.2015.1031440.]. © 2019 The Author(s). Published with license by Taylor Francis Group, LLC.Background Paroxysmal kinesigenic dyskinesia (PKD) is a movement disorder, with an excellent response to carbamazepine treatment. It has been described in various populations, but not yet in an African population. Case report In a patient who reported to clinic with side effects of carbamazepine, PRRT2 gene screening was performed based on a clinical history compatible with PKD. A co
Like
Comment
Share
